Nanobiotix is a biotech firm that specializes in developing cancer treatments, with its main one being NBTXR3 - a hafnium oxide nanoparticle suspension used to combat a variety of cancers. The company's partnership with LianBio expands its reach to countries like South Korea, Singapore, Thailand, and Greater China. Founded in 2003, Nanobiotix is headquartered in Paris, France.